EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ahcy Acts as an Effector of Hnf4a‐Driven Super‐Enhancer Activation to Alleviate MASLD During Intermittent Fasting

Huafeng Chen, Shilin Zhang, Xiaojie Deng, Wenqiang Xie iD, Fen Xu iD, Jie Shen, Hua Liang iD

Advanced Science · 2026

DOI: 10.1002/advs.76826 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Huafeng Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Fosha…. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, Super Enhancers. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Guangdong Provincial Science and Technology Innovation Strategic Special Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intermittent fasting (IF) ameliorates metabolic dysfunction‐associated steatotic liver disease (MASLD), but the underlying mechanism remains unclear. Combined CUT&Run and transcriptomic analysis shows that hepatic Ahcy is controlled by the super‑enhancer (SE) and acts as a key mediator of IF's benefit. Liver‑specific Ahcy knockout worsens high‑fat diet (HFD)‑induced hepatic steatosis and blunts the protective effect of IF. Furthermore, inhibition of Brd4 or deletion of the core SE region reduces Ahcy expression and exacerbates lipid accumulation in vivo or in vitro. Hnf4a is identified as the transcription factor driving the Ahcy‐SE. In vitro and in vivo experiments demonstrate that IF‐activated Hnf4a directly binds to and activates the Ahcy‐SE. Ahcy knockdown attenuates the lipid‐deposition‐reducing effect of Hnf4a overexpression in mice fed a HFD. In Ahcy LKO mice, the liver SAM/SAH ratio is reduced, and Reduced Representation Bisulfite Sequencing (RRBS) and transcriptome sequencing reveal liver‐specific methylation remodeling. One manifestation of this remodeling is hypermethylation of metabolic gene promoters, including the Acot12 promoter, where aberrant recruitment of Dnmt3b leads to silencing of the gene and impaired lipid hydrolysis. Therefore, these findings define an IF‐Hnf4a‐Ahcy pathway that activates SE‐driven Ahcy to orchestrate protective epigenetic reprogramming in MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatocyte Nuclear Factor 4Super EnhancersAnimalsMiceIntermittent FastingMice, KnockoutMaleLiverDiet, High-Fat

Stichwörter der Autor:innen

AhcyHnf4aMASLDintermittent fastingsuper‐enhancer

Substanzen

Hepatocyte Nuclear Factor 4Hnf4a protein, mouse

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, Guangdong, China.
  • Department of Endocrinology and Metabolism, Guangzhou First People's Hospital, Guangzhou, Guangdong, China.
  • Department of Endocrinology and Metabolism, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Medical Research Center, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, Guangdong, China.

ORCID-Profile: Wenqiang Xie, Fen Xu, Hua Liang

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Guangdong Provincial Science and Technology Innovation Strategic Special Fund
  • Scientific Research Initiation Project of Shunde Hospital of Southern Medical University

Zitieren

APA

Chen, H., Zhang, S., Deng, X., Xie, W., Xu, F., Shen, J., & Liang, H. (2026). Ahcy Acts as an Effector of Hnf4a‐Driven Super‐Enhancer Activation to Alleviate MASLD During Intermittent Fasting. Advanced Science. https://doi.org/10.1002/advs.76826

Vancouver

Chen H, Zhang S, Deng X, Xie W, Xu F, Shen J, et al. Ahcy Acts as an Effector of Hnf4a‐Driven Super‐Enhancer Activation to Alleviate MASLD During Intermittent Fasting. Advanced Science. 2026. doi:10.1002/advs.76826

BibTeX
@article{Chen2026,
  author = {Chen, Huafeng and Zhang, Shilin and Deng, Xiaojie and Xie, Wenqiang and Xu, Fen and Shen, Jie and Liang, Hua},
  title = {Ahcy Acts as an Effector of Hnf4a‐Driven Super‐Enhancer Activation to Alleviate MASLD During Intermittent Fasting},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76826}
}
Kostenlos starten →